La Jolla Pharmaceutical Company

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch LJPC and buy or sell other stocks, options, and ETFs commission-free!

About LJPC

La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics for chronic organ failure and cancer. GCS-100, the Company's lead product candidate, is a first-in-class inhibitor of galectin-3, a novel molecular target implicated in chronic organ failure and cancer. 

CEO
Larry G. Edwards
CEOLarry G. Edwards
Employees
66
Employees66
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
1989
Founded1989
Employees
66
Employees66

LJPC Key Statistics

Market cap
155.19M
Market cap155.19M
Price-Earnings ratio
59.18
Price-Earnings ratio59.18
Dividend yield
Dividend yield
Average volume
511.79K
Average volume511.79K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$6.24
52 Week high$6.24
52 Week low
$3.07
52 Week low$3.07

LJPC Earnings

-$0.10
$0.07
$0.25
$0.42
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, Pre-Market
ActualExpected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.